Cocrystal Pharma (COCP) Other Non-Current Assets (2010 - 2026)
Cocrystal Pharma (COCP) reported Other Non-Current Assets of $95000.0 for Q1 2026, up 10.47% on a YoY basis from $86000.0 in Q1 2025, and little changed sequentially from $95000.0 in Q4 2025.
Cocrystal Pharma (COCP) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Cocrystal Pharma (COCP) has 17 years of Other Non-Current Assets data on file, last reported at $95000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 10.47% year-over-year to $95000.0; the trailing twelve-month figure through Mar 2026 stood at $95000.0 (up 10.47% YoY), and the FY2025 full-year result was $95000.0, up 227.59% from the prior year.
- Other Non-Current Assets held at $95000.0 in Q1 2026, from $95000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $95000.0 in Q4 2025 to a low of $29000.0 in Q2 2024.
- A 5-year average of $56176.5 and a median of $46000.0 in 2022 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets sank 36.96% in 2024 and surged 227.59% in 2025, its largest moves.
- Tracing COCP's Other Non-Current Assets over 5 years: stood at $46000.0 in 2022, then changed by 0.0% to $46000.0 in 2023, then slumped by 36.96% to $29000.0 in 2024, then surged by 227.59% to $95000.0 in 2025, then changed by 0.0% to $95000.0 in 2026.
- Business Quant data shows COCP's Other Non-Current Assets at $95000.0 in Q1 2026, $95000.0 in Q4 2025, and $90000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 60,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 104.24 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 14.48 Mn |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | 95,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 95,000.00 |
| Dec 31, 2025 | 95,000.00 |
| Sep 30, 2025 | 90,000.00 |
| Jun 30, 2025 | 88,000.00 |
| Mar 31, 2025 | 86,000.00 |
| Dec 31, 2024 | 29,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Jun 30, 2024 | 29,000.00 |
| Mar 31, 2024 | 46,000.00 |
| Dec 31, 2023 | 46,000.00 |
| Sep 30, 2023 | 46,000.00 |
| Jun 30, 2023 | 46,000.00 |
| Mar 31, 2023 | 46,000.00 |
| Dec 31, 2022 | 46,000.00 |
| Sep 30, 2022 | 46,000.00 |
| Jun 30, 2022 | 46,000.00 |
| Mar 31, 2022 | 46,000.00 |
| Dec 31, 2021 | 46,000.00 |
| Sep 30, 2021 | 46,000.00 |
| Jun 30, 2021 | 46,000.00 |